What alternative contraceptive methods are appropriate for a 30‑year‑old woman with four children who experiences mood disturbances while using depot medroxyprogesterone acetate (Depo‑Provera) and desires reliable birth control?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Contraceptive Options for a 30-Year-Old Woman with Mood Disturbances on Depo-Provera

Switch to a long-acting reversible contraceptive (LARC) such as a copper IUD or levonorgestrel IUD, or consider the etonogestrel subdermal implant, as these methods provide highly effective contraception without the systemic progestin levels associated with Depo-Provera's mood effects. 1

Understanding the Problem with Depo-Provera

Depot medroxyprogesterone acetate (DMPA) is associated with mood disturbances in some women, including depression and emotional changes. 2, 3, 4 A randomized controlled trial demonstrated statistically significant increases in depression scores among women using DMPA compared to copper IUD users, with higher rates of major depression at 3 months postpartum. 2 These mood effects are well-documented side effects that can significantly impact quality of life and lead to method discontinuation. 3, 5, 4

First-Line Alternative: Long-Acting Reversible Contraceptives (LARCs)

Copper Intrauterine Device (Cu-IUD)

  • The copper IUD is the optimal choice for this patient because it provides highly effective contraception (failure rate <1%) without any hormonal component, completely eliminating concerns about progestin-related mood effects. 1
  • Offers 10-12 years of continuous protection without requiring user adherence beyond initial placement. 1
  • Particularly appropriate for women who have completed childbearing or desire long intervals between pregnancies. 1
  • The copper IUD is rated Category 1 (no restriction) by CDC Medical Eligibility Criteria for parous women. 6

Levonorgestrel Intrauterine Device (LNG-IUD)

  • Delivers very low systemic progestin levels compared to DMPA, with primarily local endometrial effects. 6
  • May be better tolerated than systemic progestin methods in terms of mood effects due to minimal systemic absorption. 6
  • However, there is some controversy: while epidemiological data suggest a possible increased breast cancer risk, clinical trials in breast cancer patients showed no increased recurrence rates. 6
  • For women specifically concerned about hormonal mood effects, the copper IUD remains preferable to the LNG-IUD. 6
  • Provides additional benefits of reduced menstrual bleeding and dysmenorrhea. 1

Etonogestrel Subdermal Implant

  • Another highly effective LARC option with <1% failure rate and 3-year duration. 1, 7
  • Contains a different progestin (etonogestrel) than DMPA, which may be better tolerated in terms of mood effects. 7
  • Provides steady, lower-dose progestin release compared to the high-dose depot injection. 7
  • Can be removed at any time if side effects occur, with rapid return to fertility. 7

Second-Line Alternative: Barrier Methods

Non-Hormonal Barrier Options

  • Condoms, cervical diaphragm, and cervical cap are completely hormone-free options that avoid any mood-related effects. 6
  • These methods are particularly recommended when hormonal contraception is contraindicated or poorly tolerated. 6
  • Require consistent use with each act of intercourse, making them less effective than LARCs (typical use failure rates 12-18%). 1
  • Should be combined with fertility awareness methods for improved efficacy if LARCs are declined. 6

Third-Line Alternative: Combined Hormonal Contraceptives (If No Contraindications)

Etonogestrel/Ethinyl Estradiol Vaginal Ring

  • Contains both estrogen and progestin, which may provide better mood stability than progestin-only methods in some women. 7
  • Delivers steady hormone levels with once-monthly insertion. 7
  • Critical contraindications to assess: smoking over age 35, history of thromboembolism, migraine with aura, cardiovascular disease, or hypertension. 7
  • The vaginal ring is contraindicated in women with high risk of arterial or venous thrombotic diseases. 7

Combined Oral Contraceptives (COCs)

  • May be considered if patient has no contraindications to estrogen. 6
  • Some women report improved mood stability with combined hormonal methods compared to progestin-only options. 3
  • Requires daily adherence, which may be challenging for a busy mother of four children. 1

Critical Counseling Points

Addressing Mood Concerns

  • Explicitly validate the patient's experience that mood disturbances are a recognized side effect of DMPA and a legitimate reason to switch methods. 2, 3, 4
  • Explain that non-hormonal methods (copper IUD) completely eliminate hormonal mood effects. 6, 2
  • If considering the LNG-IUD or implant, counsel that lower systemic progestin levels may result in fewer mood symptoms than DMPA. 6

Efficacy Comparison

  • Emphasize that LARCs (IUDs and implants) have failure rates <1%, which is equivalent to or better than DMPA's 0.2-0.3% perfect use failure rate. 1
  • Barrier methods are significantly less effective (12-18% typical use failure rate) but appropriate if patient strongly prefers non-hormonal, non-invasive options. 1

Return to Fertility

  • Important consideration: DMPA has delayed return to fertility (up to 9 months after last injection), whereas IUDs and implants allow immediate return to fertility upon removal. 8
  • This may be relevant even for a woman with four children who may want the option of rapid fertility return if circumstances change. 8

Common Pitfalls to Avoid

  • Do not dismiss mood symptoms as unrelated to DMPA – research clearly demonstrates this association. 2, 3, 4
  • Do not assume all progestin methods will cause the same mood effects – the high-dose, long-acting nature of DMPA may be uniquely problematic. 2, 8
  • Do not overlook the copper IUD as the most straightforward solution for hormone-related mood concerns. 6, 2
  • Do not prescribe combined hormonal methods without screening for cardiovascular risk factors including smoking, hypertension, and history of thromboembolism. 7
  • Do not limit contraceptive counseling to hormonal options – barrier methods combined with fertility awareness can be effective for motivated users. 6

References

Guideline

Depo-Provera Contraceptive Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The effect of depot medroxyprogesterone acetate on postnatal depression: a randomised controlled trial.

The journal of family planning and reproductive health care, 2016

Research

Depot-medroxyprogesterone acetate: an update.

Archives of gynecology and obstetrics, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacokinetics of depot medroxyprogesterone acetate contraception.

The Journal of reproductive medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.